• [email protected]
  • +971 507 888 742
Submit Manuscript
SciAlert
  • Home
  • Journals
  • Information
    • For Authors
    • For Referees
    • For Librarian
    • For Societies
  • Contact
  1. American Journal of Drug Discovery and Development
  2. Vol 1 (2), 2011
  3. 75-84
  • Online First
  • Current Issue
  • Previous Issues
  • More Information
    Aims and Scope Editorial Board Guide to Authors Article Processing Charges
    Submit a Manuscript

American Journal of Drug Discovery and Development

Year: 2011 | Volume: 1 | Issue: 2 | Page No.: 75-84
DOI: 10.3923/ajdd.2011.75.84

Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend



Total views 1603

Authors


A. Raja


P. Prabakarana


Keywords


  • FDA
  • actinobacteria
  • antibiotics
  • Metabolites
Review Article

Actinomycetes and Drug-An Overview

A. Raja and P. Prabakarana
This review summarizes shortly about bioactive metabolites produced by actinomycetes group. The Actinomycetes get their name from the fact that some of them form branching filaments that look kind of like the branching hyphae (collectively referred to as a mycelium) formed by fungi. In an effort to lessen confusion, Actinomycetes are now commonly referred to as Actinobacteria. Actinobacteria are neat because they tend to produce cool secondary metabolites, many of which have been successfully isolated and turned into useful drugs and other organic chemicals. In particular, an appreciable number of Actinobacteria produce antibiotics, which they use to compete with fungi and other bacteria for resources (and because they are totally badass). The genus Streptomyces (not to be confused with Streptococcus!) is a particularly fruitful source of these compounds, a number of which have been developed as antifungals, antibiotics (antibacterials) and chemotherapeutic (anticancer) drugs. Actinomycetes, mainly Streptomyces species, produce tetracyclines, aminoglycosides (streptomycin and its relatives), macrolides (erythromycin and its relatives), chloramphenicol, ivermectin, rifamycins and most other clinically useful antibiotics that are not beta-lactams. Actinomycetes are the most predominantly used in antibiotic production technology.
PDF Fulltext XML References Citation

How to cite this article

A. Raja and P. Prabakarana, 2011. Actinomycetes and Drug-An Overview. American Journal of Drug Discovery and Development, 1: 75-84.

DOI: 10.3923/ajdd.2011.75.84

URL: https://scialert.net/abstract/?doi=ajdd.2011.75.84

Related Articles

Statistical Optimization of Process Variables for Antimicrobial Metabolites Production by Streptomyces anulatus NEAE-94 Against some Multidrug-resistant Strains
Rifamycin SV Production Using Cereal Bran as Solid Substrate with Amycolatopsis mediterranei
Taxonomy and Antimicrobial Activity of Streptomyces coeruleorubidus sp. Isolated from Marine Sediment
Screening and Evaluation of Antimicrobial Activity of Tannery Fleshing Utilizing Fish Gut Bacteria
Studies on Actinomycetes Diversity in Eastern Ghats (Yercaud Hills) of Southern India for Secondary Metabolite Production
Isolation and Screening of Antibiotic Producing Psychrophilic Actinomycetes and its Nature from Rothang Hill Soil Against Viridans Streptococcus sp.

Leave a Comment


Your email address will not be published. Required fields are marked *

Useful Links

  • Journals
  • For Authors
  • For Referees
  • For Librarian
  • For Socities

Contact Us

Office Number 1128,
Tamani Arts Building,
Business Bay,
Deira, Dubai, UAE

Phone: +971 507 888 742
Email: [email protected]

About Science Alert

Science Alert is a technology platform and service provider for scholarly publishers, helping them to publish and distribute their content online. We provide a range of services, including hosting, design, and digital marketing, as well as analytics and other tools to help publishers understand their audience and optimize their content. Science Alert works with a wide variety of publishers, including academic societies, universities, and commercial publishers.

Follow Us
© Copyright Science Alert. All Rights Reserved